Published in Int Surg on November 22, 1996
Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors. J Immunol (2000) 2.07
Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol (2002) 2.03
Use of octogenarian donors for liver transplantation: a survival analysis. Am J Transplant (2014) 2.00
Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer. J Clin Oncol (1997) 1.94
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients. Br J Cancer (2005) 1.61
Treatment of a pancreatic endocrine tumor by ethanol injection (PEI) guided by endoscopic ultrasound. Endoscopy (2008) 1.56
Central nervous system side effects associated with zolpidem treatment. Clin Neuropharmacol (2000) 1.54
Changes in the transplanted ureter. Br J Exp Pathol (1965) 1.50
Expression of p53 protein and resistance to preoperative chemotherapy in locally advanced gastric carcinoma. Cancer (1998) 1.50
Resection-line involvement in gastric cancer patients undergoing curative resections: implications for clinical management. Jpn J Clin Oncol (1999) 1.48
Fat depot-related differences in gene expression, adiponectin secretion, and insulin action and signalling in human adipocytes differentiated in vitro from precursor stromal cells. Diabetologia (2007) 1.42
Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer. Clin Cancer Res (2000) 1.40
Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients. Chest (2000) 1.32
Phase II study of paclitaxel in pretreated advanced gastric cancer. Anticancer Drugs (1998) 1.31
Hepatocyte growth factor and macrophage inflammatory protein 1 beta: structurally distinct cytokines that induce rapid cytoskeletal changes and subset-preferential migration in T cells. Proc Natl Acad Sci U S A (1994) 1.25
Recombinant human erythropoietin treatment in cisplatin-associated anemia: a randomized, double-blind trial with placebo. J Clin Oncol (1994) 1.23
Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomized double-blind placebo-controlled trial. J Clin Oncol (1995) 1.18
A phase II study of weekly docetaxel as salvage chemotherapy for advanced gastric cancer. Ann Oncol (2000) 1.13
Thymidylate synthase protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil. Clin Cancer Res (1999) 1.12
Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia. Blood (2000) 1.11
Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer. Br J Cancer (2006) 1.09
Cisplatin-associated anaemia treated with subcutaneous erythropoietin. A pilot study. Br J Cancer (1993) 1.08
Human epidermal growth factor receptor 2 (HER2) in gastric cancer: a new therapeutic target. Cancer Treat Rev (2010) 1.02
Second-line chemotherapy for patients with advanced gastric cancer: who may benefit? Br J Cancer (2008) 1.01
A randomised trial of octreotide vs best supportive care only in advanced gastrointestinal cancer patients refractory to chemotherapy. Br J Cancer (1995) 1.01
Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies. Cancer (1999) 1.00
Intraabdominal pressure in liver transplant recipients: incidence and clinical significance. Transplant Proc (2004) 0.97
Serum levels of interleukin-6 as a prognostic factor in advanced non-small cell lung cancer. Oncol Rep (1998) 0.97
Tumor markers in the diagnosis of malignant serous effusions. Am J Clin Oncol (1997) 0.97
A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer. Br J Cancer (2001) 0.96
A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). Br J Cancer (1999) 0.95
Treatment of a pancreatic endocrine tumor by ethanol injection guided by endoscopic ultrasound. Endoscopy (2008) 0.94
Effects of selenium and zinc supplementation on nutritional status in patients with cancer of digestive tract. Eur J Clin Nutr (2001) 0.93
Fast track in liver transplantation: 5 years' experience. Eur J Anaesthesiol (2005) 0.93
Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator. J Interferon Cytokine Res (2001) 0.93
Clinical and technical characteristics of intraoperative radiotherapy. Analysis of the ISIORT-Europe database. Strahlenther Onkol (2013) 0.93
Serum concentrations of proinflammatory cytokines in advanced non small cell lung cancer patients. J Exp Clin Cancer Res (1998) 0.92
Disease-free survival advantage of adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with node-negative, rapidly proliferating breast cancer: a randomized multicenter study. J Clin Oncol (2000) 0.92
Weekly docetaxel and capecitabine is not effective in the treatment of advanced gastric cancer: a phase II study. Ann Oncol (2006) 0.91
Expression cDNA cloning of a novel oncogene with sequence similarity to regulators of small GTP-binding proteins. Oncogene (1994) 0.91
Octreotide versus loperamide in the treatment of fluorouracil-induced diarrhea: a randomized trial. J Clin Oncol (1993) 0.91
A phase I study of paclitaxel and 5-fluorouracil in advanced gastric cancer. Eur J Cancer (1997) 0.90
E-learning in radiology: an Italian multicentre experience. Eur J Radiol (2012) 0.90
Oral cooling (cryotherapy), an effective treatment for the prevention of 5-fluorouracil-induced stomatitis. Eur J Cancer B Oral Oncol (1994) 0.89
Evaluation of factors influencing 5-fluorouracil-induced diarrhea in colorectal cancer patients. An Italian Group for the Study of Digestive Tract Cancer (GISCAD) study. Support Care Cancer (1997) 0.89
Toxicity and therapeutic response to chemotherapy in patients aged 70 years or older with advanced cancer. Am J Clin Oncol (1996) 0.87
Mycoplasmas in human genito-urinary pathology. Pathol Microbiol (Basel) (1971) 0.87
Rectal carcinoma: CT staging with water as contrast medium. Radiology (1990) 0.86
The use of extracorporeal photopheresis for allograft rejection in liver transplant recipients. Transplant Proc (2004) 0.86
A phase I-II study of gemcitabine and docetaxel in advanced pancreatic cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). Ann Oncol (1999) 0.85
Ventricular repolarization time indexes following anthracycline treatment. Heart Vessels (1997) 0.85
Neo-adjuvant and adjuvant chemotherapy of gastric cancer. Ann Oncol (2007) 0.85
Behaviour of interleukin-2 serum levels in advanced non-small-cell lung cancer patients: relationship with response to therapy and survival. Cancer Immunol Immunother (2000) 0.85
Serum interleukin-10 is an independent prognostic factor in advanced solid tumors. Oncol Rep (2000) 0.85
Nucleophosmin/B26 regulates PTEN through interaction with HAUSP in acute myeloid leukemia. Leukemia (2012) 0.85
Preclinical and phase I study of oxaliplatin and topotecan in combination in human cancer. Ann Oncol (2002) 0.85
Oxaliplatin plus raltitrexed and leucovorin-modulated 5-fluorouracil i.v. bolus: a salvage regimen for colorectal cancer patients. Br J Cancer (2002) 0.85
Intensive weekly chemotherapy is not effective in advanced pancreatic cancer patients: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). Br J Cancer (1999) 0.85
Combined twice-daily plasma exchange and continuous veno-venous hemodiafiltration for bridging severe acute liver failure. Transplant Proc (2003) 0.84
Different doses of pamidronate in patients with painful osteolytic bone metastases. Support Care Cancer (1998) 0.84
Acute abdominal aortic thrombosis caused by paroxysmal atrial fibrillation. J Biol Regul Homeost Agents (2013) 0.84
High-dose loperamide in the treatment of 5-fluorouracil-induced diarrhea in colorectal cancer patients. Support Care Cancer (2000) 0.84
A new cisplatin/gemcitabine schedule in locally advanced (IIIB) and metastatic (IV) non-small cell lung cancer: relationship between dose-intensity and efficacy. A phase II study. Anticancer Res (2003) 0.84
3 Tesla magnetic resonance spectroscopy: cerebral gliomas vs. metastatic brain tumors. Our experience and review of the literature. Int J Neurosci (2013) 0.84
Chemotherapy for advanced pancreatic cancer: it may no longer be ignored. Ann Oncol (1999) 0.83
Inhibition of vascular endothelial growth factor by octreotide in colorectal cancer patients. Cancer Invest (2001) 0.83
Gastric cancer: The role of diffusion weighted imaging in the preoperative staging. Cancer Invest (2014) 0.83
Serum vascular endothelial growth factor (VEGF) levels correlate with tumor VEGF and p53 overexpression in endocrine positive primary breast cancer. Cancer Invest (2008) 0.83
Effects of calcium and vitamin supplementation on colon cell proliferation in colorectal cancer. Cancer Invest (2000) 0.83
Changes in jejunal motility during emotional reactions. Arch Sci Biol (Bologna) (1976) 0.83
Etoposide, leucovorin, 5-fluorouracil and interferon alpha-2b in elderly gastric cancer patients: a pilot study. Cancer Chemother Pharmacol (1994) 0.83
Soluble interleukin-2 receptor and soluble CD8 antigen levels in serum from patients with solid tumors. Int J Mol Med (1998) 0.82
Biweekly irinotecan or raltitrexed plus 6S-leucovorin and bolus 5-fluorouracil in advanced colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase II-III randomized trial. Ann Oncol (2000) 0.82
Echographic study of Tietze's syndrome. Clin Rheumatol (1991) 0.82
Cavoportal hemitransposition: patient selection criteria and outcome. Transplant Proc (2002) 0.82
Solutions for organ perfusion and storage: haemorheologic aspects. Transplant Proc (2005) 0.82
Circulating levels of soluble intercellular adhesion molecule-1 in non-small cell lung cancer patients. Oncol Rep (1998) 0.82
Double biochemical modulation of 5-fluorouracil by methotrexate and levo-folinic acid in the treatment of advanced digestive tract malignancies. Eur J Cancer (1996) 0.82
Daily low-dose subcutaneous recombinant interleukin-2 by alternate weekly administration: antitumor activity and immunomodulatory effects. Am J Clin Oncol (1998) 0.82
Traumatic carotid cavernous fistula: failure of endovascular treatment with two stent-grafts. Interv Neuroradiol (2006) 0.82
Differences of vascular endothelial growth factor (VEGF) expression between liver and abdominal metastases from colon cancer. Implications for the treatment with VEGF inhibitors. Clin Exp Metastasis (2000) 0.82
The effect of sertraline on routine blood chemistry values. Clin Neuropharmacol (2001) 0.81
The impact of everolimus on renal function in maintenance liver transplantation. Transplant Proc (2009) 0.81
An analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumour recurrence and event-free survival of patients treated with adjuvant chemoradiation. Br J Cancer (2002) 0.81
Hypercoagulable state in patients with advanced gastrointestinal cancer: evidence for an acquired resistance to activated protein C. Tumori (1998) 0.81
Mechanism of traumatic knee injuries and MRI findings. Musculoskelet Surg (2013) 0.81
A technique for successful 20 h kidney storage at 4 degrees C. Experientia (1965) 0.81
Amifostine: A selective cytoprotective agent of normal tissues from chemo-radiotherapy induced toxicity (Review). Oncol Rep (1999) 0.81
Microcirculation and reperfusion injury in organ transplantation. Adv Exp Med Biol (2005) 0.80
Recombinant human erythropoietin treatment in elderly cancer patients with cisplatin-associated anemia. Oncology (1995) 0.80
Overdose with levetiracetam: a case report and review of the literature. J Clin Pharm Ther (2012) 0.80
CT of the bowel: use of water to enhance depiction. Radiology (1988) 0.80
Pamidronate in patients with painful bone metastases, who failed initial treatment with hormones and/or chemotherapy. Support Care Cancer (1996) 0.80
Comparison of oxidative phosphorylation in the anastomosis of the small and large bowel. An experimental study in the rabbit. Eur Surg Res (1998) 0.80
Potential role and chronology of abnormal expression of the Deleted in Colon Cancer (DCC) and the p53 proteins in the development of gastric cancer. BMC Cancer (2001) 0.79